ALK appoints new Head of Product Supply
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced the appointment of Christian G. Houghton as its new Head of Product Supply, which includes all global manufacturing activities. Christian has been with ALK for 25 years and was previously Head of Chemistry, Manufacturing and Controls (CMC) & selected manufacturing sites.
Carsten Hellmann, President & CEO, said: "Christian’s experience and leadership qualities make him ideally suited to his new role and I would like to congratulate him on his appointment and welcome him as a member of ALK’s management team, where his expertise will be greatly valued."
Christian assumes responsibility for Product Supply from Søren Niegel, who took on the dual role of Head of Commercial Operations and Product Supply in November 2017.
Carsten Hellmann continued: "In 2017, we faced significant challenges in our manufacturing operations. Under Søren’s leadership, the situation has been stabilised and improved while a new product and site strategy (PASS) was established in alignment with ALK’s future commercial ambitions. With the fundamental issues in Product Supply now addressed and with PASS in place, the time is right for Søren to focus his attention on executing ALK’s commercial growth strategy as EVP for global Commercial Operations and as member of ALK's executive board."
Christian G. Houghton takes up his new role with immediate effect and reports directly to ALK’s President & CEO Carsten Hellmann.
For further information please contact:
Carsten Hellmann, President & CEO, tel. +45 4574 7576
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, tel. +45 7877 4532, mobile +45 3050 2014
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,300 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.
Upcoming Life Sciences Events
- September 2019
- Boston: 9th Annual American Drug Delivery & Formulation Summit
- Malmo: NLS Days 2019
- Boston: Redefining Early Stage Investments (RESI)
Latest company news
There are currently no news available for this portal